Detalhe da pesquisa
1.
Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients.
Ann Oncol
; 28(6): 1325-1332, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419195
2.
Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration.
Pharmacogenomics J
; 13(3): 209-17, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22310351
3.
A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer.
Br J Cancer
; 103(10): 1536-41, 2010 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-20940719
4.
First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial.
Clin Transl Oncol
; 22(4): 495-502, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31280434
5.
PrediCTC, liquid biopsy in precision oncology: a technology transfer experience in the Spanish health system.
Clin Transl Oncol
; 20(5): 630-638, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29058262
6.
Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer.
Eur J Cancer
; 37(11): 1381-4, 2001 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-11435068
7.
Neurofibromatosis type I with lung involvement in a cancer patient.
Pulmonology
; 24(4): 269-271, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30007435
8.
The value of genetic polymorphisms to predict toxicity in metastatic colorectal patients with irinotecan-based regimens.
Cancer Chemother Pharmacol
; 69(6): 1591-9, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22535333